Merz Pharma GmbH & Co KgaA-医療機器分野:企業M&A・提携分析

◆英語タイトル:Merz Pharma GmbH & Co KgaA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011019
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous system, skin and hair care, vitamins and minerals, and dental devices. It offers products for various therapeutic areas such as Alzheimer’s disease, depression, dystonia, hair loss, liver diseases, Parkinson’s disease, cold, scars, wrinkles and other skin disorders. The company also offers vitamins and minerals, and hygienic products for medical disinfection and cleaning. It operates in Australia, Switzerland, Spain, France, the US and the UK, among others. Merz Pharma is headquartered in Frankfurt am Main, Germany.

Merz Pharma GmbH & Co KgaA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deal Details 10
Venture Financing 10
Cytrellis Biosystems Raises Funds through Venture Financing 10
Cabochon Aesthetics Raises US$0.4 Million In Venture Financing 11
Ulthera Secures US$10.5 Million In Series C Venture Financing Round 12
Partnerships 13
Merz Pharma Enters into Distribution Agreement with Ulthera 13
Equity Offering 14
Ulthera Withdraws IPO 14
Acquisition 15
Merz North America Acquires ON Light Sciences 15
Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16
Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17
Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18
Merz Pharma Acquires Anteis, Aesthetics Company 19
Merz Pharma Acquires Neocutis, Dermatology Company 20
Merz Pharma GmbH & Co KgaA – Key Competitors 21
Merz Pharma GmbH & Co KgaA – Key Employees 22
Merz Pharma GmbH & Co KgaA – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Financial Announcements 25
Apr 27, 2016: Merz Pharma Announces New Investment in Cytrellis Biosystems 25
Corporate Communications 26
Apr 04, 2017: Merz Appoints Bob Rhatigan as President and Chief Executive Officer in North America 26
Product News 27
May 18, 2017: Merz Celebrates a Monumental Milestone: One Million Treatments Worldwide With Ultherapy 27
Other Significant Developments 28
Nov 21, 2016: Merz Continues Its Growth in Aesthetics and Neurotoxins 28
Apr 27, 2016: Merz Pharma Announces New Investment in Cytrellis Biosystems 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Merz Pharma GmbH & Co KgaA, Medical Equipment, Key Facts 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Merz Pharma GmbH & Co KgaA, Deals By Market, 2011 to YTD 2017 8
Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cytrellis Biosystems Raises Funds through Venture Financing 10
Cabochon Aesthetics Raises US$0.4 Million In Venture Financing 11
Ulthera Secures US$10.5 Million In Series C Venture Financing Round 12
Merz Pharma Enters into Distribution Agreement with Ulthera 13
Ulthera Withdraws IPO 14
Merz North America Acquires ON Light Sciences 15
Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16
Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17
Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18
Merz Pharma Acquires Anteis, Aesthetics Company 19
Merz Pharma Acquires Neocutis, Dermatology Company 20
Merz Pharma GmbH & Co KgaA, Key Competitors 21
Merz Pharma GmbH & Co KgaA, Key Employees 22
Merz Pharma GmbH & Co KgaA, Other Locations 23
Merz Pharma GmbH & Co KgaA, Subsidiaries 23

★海外企業調査レポート[Merz Pharma GmbH & Co KgaA-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Duopharma Biotech Berhad (DPHARMA):企業の財務・戦略的SWOT分析
    Summary Duopharma Biotech Berhad (Duopharma), formerly CCM Duopharma Biotech Berhad, focuses on research, development and commercialization of generic drugs and biosimilars. The company manufactures and distributes pharmaceutical products to treat oncology and diabetes; musculo-skeletal, alimentary …
  • Hycor Biomedical Inc-医療機器分野:企業M&A・提携分析
    Summary Hycor Biomedical Inc (Hycor) is a medical device company that manufactures and markets in-vitro diagnostic products. The company offers products such as auto immune testing systems, allergy testing systems, HYTEC plus and HYCOR ultrasensitive EIA products. Its auto immune testing products co …
  • Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析
    Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PolyNovo Ltd (PNV)-医療機器分野:企業M&A・提携分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company offers products such as biodegradable temporizing matrix and negative pressure wound therapy dressing system …
  • Sfinks Polska S.A.
    Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sisaf Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Cerenis Therapeutics Holding SA (CEREN):企業の財務・戦略的SWOT分析
    Summary Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company develops a portfolio of HDL therapies including HDL mimetics for the rapid regression of atherosclerotic …
  • Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析
    Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Papyrus Australia Limited (PPY):企業の財務・戦略的SWOT分析
    Papyrus Australia Limited (PPY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Conatus Pharmaceuticals Inc (CNAT):企業の財務・戦略的SWOT分析
    Summary Conatus Pharmaceuticals Inc (Conatus) is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the act …
  • Pavmed Inc (PAVM):企業の製品パイプライン分析2018
    Summary Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; P …
  • Betta Pharmaceuticals Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Betta Pharmaceuticals Co Ltd (Betta Pharma) is a developer and manufacturer of drugs for treating cancer, cardiovascular diseases and diabetes. The company’s product includes conmana, a selective epidermal growth factor receptor tyrosine kinase inhibitor indicated for treating locally advanc …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Zion Oil & Gas Inc (ZN):石油・ガス:M&Aディール及び事業提携情報
    Summary Zion Oil & Gas Inc (Zion Oil) is an oil and gas company that explores and produces oil and gas properties in Israel. The company offers services such as geophysical, geological, and other science-based studies and surveys to support oil and gas exploration and development services. It holds …
  • 3M Company:企業のM&A・事業提携・投資動向
    3M Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3M Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Societe Generale S.A.:企業の戦略・SWOT・財務情報
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kering SA (KER):企業の財務・戦略的SWOT分析
    Kering SA (KER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Merck KGaA (MRK):企業の財務・戦略的SWOT分析
    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nihon Kohden Corporation:企業の戦略・SWOT・財務情報
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Intersect ENT Inc (XENT):企業の財務・戦略的SWOT分析
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Intersect …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆